Erasca, Inc. Increase (Decrease) in Accounts Payable
Erasca, Inc. (ERAS) reported Increase (Decrease) in Accounts Payable of $970.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-11
- Erasca, Inc. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was -$212.00K.
- Erasca, Inc. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $1.18M, a 34.11% decline year-over-year.
- Erasca, Inc. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was -$2.05M.
- Erasca, Inc. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was $1.37M, a 183.40% increase year-over-year.
- Erasca, Inc. increase (decrease) in accounts payable for fiscal 2025 was $513.00K.
- Erasca, Inc. increase (decrease) in accounts payable for fiscal 2024 was -$1.53M.
- Erasca, Inc. increase (decrease) in accounts payable for fiscal 2023 was -$886.00K, a 231.07% decline from fiscal 2022.
- Erasca, Inc. increase (decrease) in accounts payable for fiscal 2022 was $676.00K, a 49.70% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$212.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $970.00K 10-Q · filed 2026-08-11 | -$1.08M derived: sum of 3 quarters · filed 2026-08-11 | $288.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $1.18M 10-Q · filed 2026-05-11 | -$866.00K derived: sum of 2 quarters · filed 2026-05-11 | $500.00K derived: sum of 3 quarters · filed 2026-05-11 | -$99.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | -$2.05M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$682.00K derived: sum of 2 quarters · filed 2026-03-12 | -$1.28M derived: sum of 3 quarters · filed 2026-08-11 | $513.00K 10-K · filed 2026-03-12 |
| 2025-09-30 | $1.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $767.00K derived: sum of 2 quarters · filed 2026-08-11 | $2.56M 10-Q · filed 2025-11-12 | $624.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | -$599.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $1.20M 10-Q · filed 2026-08-11 | -$742.00K derived: sum of 3 quarters · filed 2026-08-11 | -$260.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $1.79M 10-Q · filed 2026-05-11 | -$143.00K derived: sum of 2 quarters · filed 2026-05-11 | $339.00K derived: sum of 3 quarters · filed 2026-05-11 | -$371.00K derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | -$1.94M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$1.46M derived: sum of 2 quarters · filed 2026-03-12 | -$2.17M derived: sum of 3 quarters · filed 2026-03-12 | -$1.53M 10-K · filed 2026-03-12 |
| 2024-09-30 | $482.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$228.00K derived: sum of 2 quarters · filed 2025-11-12 | $405.00K 10-Q · filed 2025-11-12 | -$1.26M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | -$710.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$77.00K 10-Q · filed 2025-08-12 | -$1.74M derived: sum of 3 quarters · filed 2025-08-12 | -$708.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $633.00K 10-Q · filed 2025-05-13 | -$1.03M derived: sum of 2 quarters · filed 2025-05-13 | $2.00K derived: sum of 3 quarters · filed 2025-05-13 | -$699.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | -$1.66M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | -$631.00K derived: sum of 2 quarters · filed 2025-03-20 | -$1.33M derived: sum of 3 quarters · filed 2025-03-20 | -$886.00K 10-K · filed 2025-03-20 |
| 2023-09-30 | $1.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $331.00K derived: sum of 2 quarters · filed 2024-11-12 | $777.00K 10-Q · filed 2024-11-12 | -$87.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | -$701.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | -$255.00K 10-Q · filed 2024-08-12 | -$1.12M derived: sum of 3 quarters · filed 2024-08-12 | $407.00K derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $446.00K 10-Q · filed 2024-05-08 | -$418.00K derived: sum of 2 quarters · filed 2024-05-08 | $1.11M derived: sum of 3 quarters · filed 2024-05-08 | -$776.00K derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | -$864.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $662.00K derived: sum of 2 quarters · filed 2024-03-27 | -$1.22M derived: sum of 3 quarters · filed 2024-03-27 | $676.00K 10-K · filed 2024-03-27 |
| 2022-09-30 | $1.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$358.00K derived: sum of 2 quarters · filed 2023-11-09 | $1.54M 10-Q · filed 2023-11-09 | $2.48M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$1.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $14.00K 10-Q · filed 2023-08-10 | $949.00K derived: sum of 3 quarters · filed 2023-08-10 | $778.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $1.90M 10-Q · filed 2023-05-15 | $2.83M derived: sum of 2 quarters · filed 2023-05-15 | $2.66M derived: sum of 3 quarters · filed 2023-05-15 | $3.07M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $935.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $764.00K derived: sum of 2 quarters · filed 2023-03-23 | $1.17M derived: sum of 3 quarters · filed 2023-03-23 | $1.34M 10-K · filed 2023-03-23 |
| 2021-09-30 | -$171.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $234.00K derived: sum of 2 quarters · filed 2022-11-09 | $409.00K 10-Q · filed 2022-11-09 | -$983.00K derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $405.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $580.00K 10-Q · filed 2022-08-11 | -$812.00K derived: sum of 3 quarters · filed 2022-08-11 | $721.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $175.00K 10-Q · filed 2022-05-12 | -$1.22M derived: sum of 2 quarters · filed 2022-05-12 | $316.00K derived: sum of 3 quarters · filed 2022-05-12 | |
| 2020-12-31 | -$1.39M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $141.00K derived: sum of 2 quarters · filed 2022-03-24 | -$380.00K 10-K · filed 2022-03-24 | |
| 2020-09-30 | $1.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $1.01M 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | -$521.00K 10-Q · filed 2021-08-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |